Related Experiment Video
Updated: Aug 9, 2026

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
Published on: April 3, 2026
Pathology of the vulnerable plaque
Renu Virmani1, Allen P Burke, Andrew Farb
1CVPath, International Registry of Pathology, Gaithersburg, Maryland 20878, USA. rvirmani@cvpath.org
Insights
Thin cap fibroatheroma (TCFA) is a precursor lesion for acute coronary syndromes (ACS), often found in proximal arteries. Identifying TCFAs in living patients may help prevent sudden cardiac death.
Area of Science:
- Cardiovascular Pathology
- Interventional Cardiology
- Biomarkers of Atherosclerosis
Background:
- Acute coronary syndromes (ACS) result from coronary thrombosis, primarily plaque rupture or erosion.
- Thin cap fibroatheroma (TCFA) is a non-thrombosed lesion resembling acute plaque rupture.
- Recognizing ACS precursor lesions is crucial for advancing coronary disease treatment.
Purpose of the Study:
- To characterize the thin cap fibroatheroma (TCFA) as a precursor lesion for acute coronary syndromes (ACS).
- To identify the prevalence and characteristics of TCFAs in relation to ACS.
- To explore the potential of TCFA identification in preventing sudden coronary death.
Main Methods:
- Histopathological analysis of coronary artery lesions in patients with ACS.
- Morphometric measurements of TCFA components (necrotic core, fibrous cap).
- Correlation of TCFA presence with clinical risk factors and arterial location.
Main Results:
- TCFAs, characterized by a thin fibrous cap (<65 microm) and necrotic core, are the primary precursor to plaque rupture in ACS.
- TCFAs are most prevalent in proximal coronary arteries and associated with positive remodeling, not severe stenosis.
- TCFAs are linked to high total cholesterol, elevated TC/HDL ratio, postmenopausal women, and high-sensitivity C-reactive protein levels.
Conclusions:
- Thin cap fibroatheroma (TCFA) is a critical precursor lesion for acute plaque rupture in acute coronary syndromes (ACS).
- TCFA identification in living patients offers a potential strategy to reduce sudden coronary death.
- Further research into TCFA detection and management is warranted for ACS prevention.
Abstract:
The majority of patients with acute coronary syndromes (ACS) present with unstable angina, acute myocardial infarction, and sudden coronary death. The most common cause of coronary thrombosis is plaque rupture followed by plaque erosion, whereas calcified nodule is infrequent. If advances in coronary disease are to occur, it is important to recognize the precursor lesion of ACS. Of the three types of coronary thrombosis, a precursor lesion for acute rupture has been postulated. The non-thrombosed lesion that most resembles the acute plaque rupture is the thin cap fibroatheroma (TCFA), which is characterized by a necrotic core with an overlying fibrous cap measuring <65 microm, containing rare smooth muscle cells but numerous macrophages. Thin cap fibroatheromas are most frequently observed in patients dying with acute myocardial infarction and least common in plaque erosion. They are most frequently observed in proximal coronary arteries, followed by mid and distal major coronary arteries. Vessels demonstrating TCFA do not usually show severe narrowing but show positive remodeling. In TCFAs the necrotic core length is approximately 2 to 17 mm (mean 8 mm) and the underlying cross-sectional area narrowing in over 75% of cases is <75% (diameter stenosis <50%). The area of the necrotic core in at least 75% of cases is < or =3 mm2. These lesions have lesser degree of calcification than plaque ruptures. Thin cap fibroatheromas are common in patients with high total cholesterol (TC) and high TC/high-density lipoprotein cholesterol ratio, in women >50 years, and in those patients with elevated high levels of high sensitivity C-reactive protein. It has only recently been recognized that their identification in living patients might help reduce the incidence of sudden coronary death.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
